Back
Traws Pharma Stock Price Chart
Sponsored
TRAW
Sponsored
Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings
Analyze Any Stock Free
Buy
56
TRAW
Traws Pharma
Last Price:
$8.08
Seasonality Move:
4.31%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free-
The current trend is moderately bullish and TRAW is experiencing selling pressure, which indicates risk of future bearish movement.
Traws Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.61 | Sell |
20-day SMA: | 7.88 | Buy |
50-day SMA: | 6.14 | Buy |
200-day SMA: | 10.39 | Sell |
8-day EMA: | 8.66 | Sell |
20-day EMA: | 8.04 | Buy |
50-day EMA: | 6.98 | Buy |
200-day EMA: | 9.95 | Sell |
Traws Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.86 | Buy |
Relative Strength Index (14 RSI): | 52.1 | Buy |
Chaikin Money Flow: | -25647 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.59 - 10.03) | Buy |
Bollinger Bands (100): | (4.47 - 8.67) | Buy |
Traws Pharma Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Traws Pharma Stock
Is Traws Pharma Stock a Buy?
-
Traws Pharma share price is 8.06 while TRAW 8-day simple moving average is 8.61, which is a Sell signal.
-
The stock price of TRAW is 8.06 while Traws Pharma 20-day SMA is 7.88, which makes it a Buy.
-
Traws Pharma 50-day simple moving average is 6.14 while TRAW share price is 8.06, making it a Buy technically.
-
TRAW stock price is 8.06 and Traws Pharma 200-day simple moving average is 10.39, creating a Sell signal.
TRAW Technical Analysis vs Fundamental Analysis
Buy
56
Traws Pharma (TRAW)
is a Buy
Is Traws Pharma a Buy or a Sell?
-
Traws Pharma stock is rated a BuyThe current Traws Pharma [TRAW] share price is $8.06. The Score for TRAW is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Traws Pharma Stock Info
Market Cap:
24.4M
Price in USD:
8.06
Share Volume:
27.7K
Traws Pharma 52-Week Range
52-Week High:
27.50
52-Week Low:
4.06
Buy
56
Traws Pharma (TRAW)
is a Buy
Traws Pharma Share Price Forecast
-
What is the Traws Pharma stock price today?The Traws Pharma stock price is 8.06 USD today.
-
Will TRAW stock go up or go down?Traws Pharma> share price is forecast to RISE/FALL based on technical indicators
-
Is Traws Pharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Traws Pharma is not overvalued.
Is Traws Pharma Stock a Buy?
-
Traws Pharma share price is 8.06 while TRAW 8-day exponential moving average is 8.66, which is a Sell signal.
-
The stock price of TRAW is 8.06 while Traws Pharma 20-day EMA is 8.04, which makes it a Buy.
-
Traws Pharma 50-day exponential moving average is 6.98 while TRAW share price is 8.06, making it a Buy technically.
-
TRAW stock price is 8.06 and Traws Pharma 200-day simple moving average is 9.95, creating a Sell signal.
Technical Analysis of Traws Pharma
Should I short Traws Pharma stock?
-
TRAW Moving Average Covergence Divergence (MACD) indicator is 0.86, suggesting Traws Pharma is a Buy
-
Traws Pharma Relative Strength Index (RSI) is 52.1, which suggest Traws Pharma is overbought
-
The Bollinger Bands (25) for Traws Pharma is (4.59 - 10.03), which suggest Traws Pharma is a Buy
-
The Bollinger Bands (100) for Traws Pharma is (4.47 - 8.67), which suggest Traws Pharma is a Buy
* Traws Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.